Cancer Treatment (Oncology) · Daejeon, South Korea
Breast cancer treatment cost in Daejeon
Treatments from
$362
Options priced
1 of 13
Treatment options · Daejeon
one pathway per patient — never summed
- Magnetic Resonance Imaging (MRI) diagnostic from $362
How we collect & verify prices Compare treatments ↓
In plain words · A tumor that starts in breast tissue — highly treatable when found early; treatment usually combines surgery with drug or radiation therapy.
Also known as: breast tumorbreast carcinoma
- Treatments from
- $362
- cheapest single option
- Options priced
- 1 of 13
- treatment menu
- MCI Index
- 40
- B
- Clinics
- 5
- in Daejeon
- Specialists
- 7
- who treat this
Top hospital for this in Daejeon · Newsweek #19 in South Korea
#19 Chungnam National University Hospital 3.2★ KOIHA 의료기관인증 (Korea Institute for Healthcare Accreditation) — 상급종합병원/급성기 (tertiary hospital, acute-care) certification
Chungnam National University Hospital (충남대학교병원) is a public national-university tertiary teaching hospital (상급종합병원) in Munhwa-ro, Jung-gu, Daejeon, established 1972 as the first teaching hospital in Korea's central Chungcheong region. It is affiliated with Chungnam National University College of Medicine and is distinct from its own 2020-opened sister campus, Sejong Chungnam National University Hospital, and from Chonnam National University Hospital (전남/Jeollanam-do) and Chonnam National University-Hwasun Hospital, unrelated institutions with similar-sounding romanized names. It holds current KOIHA acute-care/tertiary accreditation (cert 4-15, valid 2023-02-07 to 2027-02-06, directory-verified via 소비자24); no JCI accreditation is claimed. Its own 2025-12 hospital-status dashboard reports 1,186 operating beds (down from 1,409 in 2015, per its own decade-long facilities chart), while its KOIHA registry entry separately lists 1,303 licensed beds — both cited rather than averaged. It runs a Gamma Knife radiosurgery center, organ- and hematopoietic-stem-cell-transplant programs, a critical care center, and a regionally-designated rare-disease referral institution, alongside a broad roster of clinical departments spanning internal medicine subspecialties, surgery, women's/children's health, and dentistry. Its own mandated 비급여 (non-covered) fee disclosure carries a dental-implant line (1.9-3.0M won per tooth, materials included), manual therapy (33,000-55,100 won/day), musculoskeletal ESWT (134,000-294,100 won), and a flat-priced brain MRI menu (741,800 won regardless of contrast or field strength) — but no plain diagnostic CT line item was found anywhere in its disclosure database. Its Comprehensive Health Promotion Center separately publishes self-pay screening-program prices from an entry '2030검진' tier (450,000/500,000 won) up to a top cerebro/cardiovascular precision tier (3.5-3.99M won); no separate foreigner-package pricing was found on its International Healthcare Center page.
Treatment options in Daejeon from $362 — full menu below.
Treatments & prices in Daejeon
VerifiedEvery treatment this condition maps to, cheapest first — diagnostics before treatments. Each links to its full price comparison. One pathway per patient; we never sum options into a fake total.
| Treatment | Type | Local price | from ≈USD | Status |
|---|---|---|---|---|
| Magnetic Resonance Imaging (MRI) | diagnostic | ₩540,000–₩741,800 | $362 | Verified |
Each treatment links to its full price page — clinic prices, other cities, recovery and risks.
What treatment costs at each stage
Modeled previewStaging system: TNM (AJCC), commonly grouped as stage 0–IV. Stage is set by tumor size, nodes and spread — it decides which treatment anchors your cost, which is why condition prices span so widely.
- Stage 0 (in situ) Surgery, often with radiation Not yet priced
- Stage I–II (early) Surgery ± radiation; systemic therapy per case Not yet priced
- Stage III (locally advanced) Systemic therapy + surgery + radiation Not yet priced
- Stage IV (metastatic) Ongoing systemic therapy (hormonal, targeted, chemo) Not yet priced
The stage→treatment map is a modeled framework from public clinical taxonomy; prices are this registry's own rows for mapped treatments — empty means we haven't priced it, never a guess. Your stage and pathway are the specialist's call.
What diagnosis costs in Daejeon
ImportedYour first spend is the work-up, not the treatment — the typical items, priced from this registry where we hold them.
- 1 Specialist consultation Not yet priced
- 2 Imaging — mammogram Not yet priced
- 3 Image-guided biopsy Not yet priced
- 4 Pathology review Not yet priced
- 5 Staging imaging (CT / PET / MRI) Magnetic Resonance Imaging (MRI) $362–$497
Consultation fees from our specialist registry; procedure prices from this condition's mapped diagnostics. Unverified prices are labeled on their own pages.
Breast cancer in other cities
ImportedThe same care market across the registry — cheapest entry first. Cheapest ≠ best: the MCI column grades each market as its data lands.
- Public-system wait at home (UK)NHS England referral-to-treatment statistics, Apr 2026 · Canada (CIHI) next 11.9-week median
- Recruiting breast cancer trials in South KoreaClinicalTrials.gov — recruiting "breast cancer" studies with a South Korea site · queried 2026-07-09 121 studies
- JCI-accredited organizations in South KoreaJCI public directory, country-wide (all specialties) Not yet sourced
Cheapest entry price per city with the size of its priced treatment menu and specialist density — countable signals only, "—" is never guessed.
Hospitals & clinics in Daejeon
Best firstThe best hospitals first — Newsweek World's Best national top 10 lead, then our connected-chain grade. Re-rank by rating or reviews.
Destination-safety factor for South Korea: ×1.00 — Level 1 — Exercise Normal Precautions (the lowest advisory tier) (US State Dept Travel Advisory, 2025-08). Applies equally to every hospital here; it separates this market from higher-risk destinations.
- Chungnam National University Hospital #19 Sourced profile
multi-specialty KOIHA 의료기관인증 (Korea Institute for Healthcare Accreditation) — 상급종합병원/급성기 (tertiary hospital, acute-care) certification 3.2 Google 1,186 beds
71 Grade - The Catholic University of Korea Daejeon St. Mary's Hospital #75 Sourced profile
multi-specialty KOIHA 3.6 Google 657 beds
68 Grade - Daejeon Sun Medical Center #82 Sourced profile
multi-specialty KOIHA 급성기병원 인증 (Acute-Care Hospital Accreditation) 3.6 Google 328 beds
67 Grade - Yuseong Sun Medical Center #92 Sourced profile
multi-specialty KOIHA 의료기관인증 (Korea Institute for Healthcare Accreditation, 급성기 acute-care type) 3.6 Google 329 beds
66 Grade - 63 Grade
Who gets breast cancer
VerifiedScale of the condition from the global cancer registry — context for why this care market exists.
New cases
2.3M
worldwide in 2022 — the most common cancer in women · IARC GLOBOCAN 2022
Deaths
666,000
worldwide in 2022 · IARC GLOBOCAN 2022
Share of cancers in women
23.8%
of all new cancer cases in women, 2022 · IARC GLOBOCAN 2022
Second opinion first — before you commit
Not yet sourcedHaving your existing diagnosis re-read here is the cheapest way to test a hospital's quality before booking anything. Prices land per hospital with sources — never estimated.
- Remote records review — written second opinion your existing scans, pathology and reports, reviewed without flying Not yet priced
- Video consultation with a specialist live case discussion after the review Not yet priced
- In-person specialist consultation reference price if you're already here Not yet priced
A second opinion changes the plan often enough that specialists expect to be asked for one — it's a normal request, not an insult. Remote-review prices are being collected per hospital.
The care pathway
Modeled previewHow the treatment decision is typically made for this condition — your specialist confirms the path for your case.
- 1
See the right specialist
Care for breast cancer starts with a specialist, who confirms the diagnosis and plans the next steps.
- 2
Diagnosis & tests
The diagnosis is confirmed with Breast Cancer X-ray Screening (Mammogram), Stereotactic Breast Biopsy or Magnetic Resonance Imaging (MRI), which also show how far it has progressed (staging).
- 3
Treatment options
Options include Breast Reconstruction Surgery, Hormonal Therapy (Endocrine Therapy for breast, prostate, thyroid cancers), Hormonal Therapy for Breast Cancer, Reconstructive Surgery (e.g., breast prostheses), Mastectomy, Lumpectomy, Radiation Therapy, Chemotherapy, Targeted Therapy or Immunotherapy — weighed on outcome, downtime, risk and total cost. See the priced menu and decision factors below.
- 4
Treatment
The chosen treatment plan is carried out — every option below links to its own price page with a recovery timeline.
- 5
Follow-up & monitoring
Scheduled scans and check-ups confirm the result and catch any recurrence early; remote follow-up is common for international patients.
Framework pathway modeled by field — per-condition clinical pathways replace it as they're sourced.
Who you'll see — the care team
Modeled previewSpecialist types by pathway phase — never named individuals — with real consultation fees where we hold them. Each links to its own price page.
- Diagnosis Radiologist reads your imaging Fee not yet priced
- Diagnosis Pathologist confirms the diagnosis from the biopsy Fee not yet priced
- Decision & systemic treatment Oncologist stages the disease and owns the treatment plan Fee not yet priced
- Local treatment Radiation therapist plans and delivers radiotherapy Fee not yet priced
Fees are city-level consultation ranges from our specialist registry (imported, re-verified over time). Doctors are hospital attributes — you choose the provider on its hospital page, never a named individual here.
Choosing between the options
Modeled previewWhat actually decides between the treatments above — and the checklist an expert would put to the specialist.
Decision factors
- 1How advanced the condition is — stage or severity narrows the menu first
- 2Your goal: cure, control, symptom relief or appearance
- 3Downtime you can afford — the options below differ by weeks
- 4Total cost with travel and follow-up, not just the sticker price
- 5Tumor biology — some options only work for specific types
Ask the specialist
- 1Will my case be reviewed by a multidisciplinary tumor board?
- 2How many of this exact procedure did you perform last year?
- 3What is your complication and revision rate for it?
- 4What anesthesia will be used, and who administers it?
- 5Who manages my aftercare once I fly home, and how?
- 6What exactly is included in the quoted price — and what isn't?
A planning frame — suitability is always the specialist's call.
South Korea for medical travel — safety, recourse & visa
Sourced Full South Korea guide →What matters if it goes wrong, and what it takes to get there — country-level, verifiable guidance in one place.
- Visa
- Most Western nationalities (US, UK, EU/Schengen, Australia, Canada, New Zealand, Japan) enter visa-free for short medical or tourist visits. The K-ETA (electronic travel authorization) requirement is temporarily WAIVED for 67 countries and territories through 31 December 2026 — eligible travellers enter without applying for a K-ETA; the requirement is expected to resume 1 January 2027. Confirm your nationality's current rule before travelling.
- Medical / long-stay visa
- For treatment, foreign patients typically use the C-3-3 medical tourism visa (short-term, stays up to 90 days, generally not extendable beyond 90 days except in special circumstances). For treatment or recovery longer than 90 days, patients change to or apply for the G-1-10 long-term medical treatment visa, which can be extended inside Korea; it requires hospital documentation (medical opinion, treatment schedule, payment records). Applications must be tied to a medical institution registered with KTO/KHIDI.
- Arrival
- From 1 January 2026, all foreign arrivals must file the mandatory digital e-Arrival Card online (within 3 days before arrival) — it replaces the paper disembarkation card and is a declaration, not a visa. Travellers who hold an approved K-ETA are exempt from the arrival card, but nationals of K-ETA-waived countries (US, UK, EU, Japan, etc.) must still complete the e-Arrival Card.
- Currency
- South Korean Won (KRW, ₩)
- Languages
- Korean; English widely spoken in international-patient centers at major hospitals, with interpreter services in multiple languages
- Traveller safety
- Very safe for visitors
- Legal recourse
- Established malpractice recourse
- Insurance
- Medical-travel & complication cover widely available
- International patients
- Hospitals accustomed to international patients
General guidance from public sources — confirm current rules for your nationality. Verified against: Korea Immigration — K-ETA temporary exemption extended to 31 Dec 2026 (MOFA/KPMG GMS alert) · Korea e-Arrival Card mandatory from 1 Jan 2026 · Medical Korea — medical visa (C-3-3 / G-1-10), KHIDI · MOHW — Korea attracts 1.17 million foreign patients in 2024.
Medical Travel Cost Condition Index
MCI · Method 1.3 Methodology →One comparable grade for this city's care market for the diagnosis — treatment coverage, price, evidence, choice and provider trust on the same public formula. Unsourced metrics are excluded, never guessed.
100% of the formula backed by data
- Treatment coverage 8 Imported 1 of 13 options priced · share of this condition's treatment menu priced here
- Price competitiveness 36 Imported cheaper than 36% of cities · vs 39 cities treating this condition · 36th percentile
- Price evidence 55 ✓ Verified 1 priced option · sourced/verified prices behind the treatment menu
- Provider choice 60 Imported 5 clinics · specialty providers in this city
- Provider trust 63 Our index 63/100 top · best provider's Trust Index
Same method as every page in the registry. Machine-readable version below for models & crawlers.
Specialists & related conditions
DirectoryWho treats breast cancer, and nearby diagnoses in the same field.
Dots carry the lens colors — teal opens a specialist page, red another condition, both priced for Daejeon.
Common questions
Sourced + modeledShort answers built from the numbers on this page — costs, pathway, providers and verification.
How much does breast cancer treatment cost in Daejeon?
1 treatment option are priced here, starting from ≈ $362 for the cheapest single treatment. Most patients follow one pathway — the options are never summed.
What does breast cancer diagnosis cost in Daejeon?
Diagnosis comes before any treatment decision: 1 of the 5 typical work-up items are priced here (specialist consultation, imaging, biopsy), together ≈ $362–$497 if your work-up needs every priced step. Items we haven't priced yet are listed without numbers.
Which treatment will I actually need?
That's a specialist's call after diagnosis and staging — the care pathway below shows how the decision is made. Each option links to its own price page with recovery details.
Who treats breast cancer in Daejeon?
5 cancer treatment (oncology) and multi-specialty providers are listed for Daejeon, with a top Trust Index of 63. We list them as a directory — availability is confirmed on each hospital's page.
Are these prices verified?
1 of the 1 priced options are manually verified against a published source; the rest are labeled imported until checked.
Is it safe to be treated in South Korea?
Very safe for visitors for visitors, and established malpractice recourse. Hospital-level signals (accreditation, Trust Index) are per provider — see the directory below.
Data & sources
40% verified Methodology →How much of this page is verified data — every section carries a chip telling you where its numbers come from.
All 10 data fields — what's verified, imported or modeled Show more Hide
- Treatment prices· 1 of 13 options ✓ Verified
- Cross-city comparison· 39 priced Imported
- Provider directory· 5 clinics Imported
- Care pathway & decision factors· sourced per-condition ✓ Verified
- Stage → cost map· TNM (AJCC), commonly grouped as stage 0–IV Modeled
- Diagnosis price basket· 1 of 5 priced Imported
- Prevalence & guidelines· IARC GLOBOCAN 2022 ✓ Verified
- Second opinion & fly-or-stay math Not yet collected
- Outcome benchmarks· slots ready — feed the Index Not yet collected
- Visa & travel guidance ✓ Verified
Every field is tagged by source state. "Verified" = sourced and checked; "Imported" = real data pending re-verification; "Modeled" = deterministic placeholder for this preview; "Not yet collected" = on our roadmap. Confidence feeds the Medical Travel Cost Index.
Clinical practice guidelines — who sets the treatment standard
- NCCN (US) — Clinical Practice Guidelines in Oncology — Breast Cancer · updated annually Reference
- ESMO (Europe) — Clinical Practice Guidelines — early & metastatic breast cancer Reference
- NICE (UK) — NG101 — Early and locally advanced breast cancer Reference
Cited as the bodies that define the standard of care — we never summarize guidelines into medical advice.